Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole

NCT00982904 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Human African Trypanosomiasis

Interventions

DRUG: Fexinidazole/Placebo

Sponsor

Drugs for Neglected Diseases

Collaborators

[object Object]